Macquarie Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Macquarie Group’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-373	Closed	-$4K	–	1956
2019 Q2	$4K	Buy	+373	New	+$6.86K	﹤0.01%	1819
2019 Q1	–	Sell	-255	Closed	-$6K	–	2237
2018 Q4	$6K	Buy	+255	New	+$9.97K	﹤0.01%	2081
2018 Q1	–	Sell	-250	Closed	-$32K	–	2487
2017 Q4	$32K	Buy	+250	New	+$32K	﹤0.01%	2121
2016 Q1	–	Sell	-3,136	Closed	-$629K	–	1611
2015 Q4	$629K	Sell	3,136 -410	-12%	-$81.8K	﹤0.01%	1140
2015 Q3	$529K	Buy	3,546 +1,357	+62%	+$996K	﹤0.01%	1234
2015 Q2	$2.08M	Buy	2,189 +587	+37%	+$480K	﹤0.01%	1019
2015 Q1	$1.17M	Buy	+1,602	New	+$1.2M	﹤0.01%	1122

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Macquarie Group's TTPH Position: Q3 2019 in Review

Macquarie Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 373 shares — an estimated $4K sold.

Macquarie Group first reported a position in TTPH in Q1 2015 and held it in 7 quarters. The position peaked at $2.08M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

Macquarie Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Macquarie Group sold 373 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $4K.
Macquarie Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
Macquarie Group's Tetraphase Pharmaceuticals, Inc. position peaked at $2.08M in Q2 2015.
26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Macquarie Group's 13F filing for Q3 2019, filed 14 Nov 2019.